VEGFA and neoplasm: Monoclonal antibodies are well established as anticancer therapeutics, one example being an antibody to VEGF-A, known as bevacizumab or Avastin®, that is designed to restrict tumour angiogenesis and used to treat patients with metastatic colorectal cancer (Ferrara et al, 2004).